Nimbus CEO Talks $4bn Takeda Deal And Capital Cycles

 
• By David Wild
  
Nimbus Therapeutics Closed One of the Largest Single-Asset Deals in Biotech History • Source: Shutterstock
In Vivo Podcast

Candid conversations with C-suite leaders.

Keep up with strategy, innovation and evolving trends across life science industries.

SpotifyApple PodcastsWebsite

More from Deal-Making

More from In Vivo